These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16330939)

  • 1. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2006 Jan; 30(1):28-35. PubMed ID: 16330939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
    Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
    Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma.
    Turner JR; Torres CM; Wang HH; Shahsafaei A; Richards WG; Sugarbaker D; Odze RD
    Hum Pathol; 2000 Mar; 31(3):347-53. PubMed ID: 10746678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy.
    Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Am J Surg Pathol; 2013 Jan; 37(1):47-52. PubMed ID: 23060350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
    Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
    Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
    Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
    de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
    Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases.
    Paraf F; Fléjou JF; Pignon JP; Fékété F; Potet F
    Am J Surg Pathol; 1995 Feb; 19(2):183-91. PubMed ID: 7832278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus.
    Collard JM; Romagnoli R; Hermans BP; Malaise J
    Am J Surg; 1997 Sep; 174(3):307-11. PubMed ID: 9324143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
    Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of adenocarcinoma arising in Barrett's esophagus.
    Hoff SJ; Sawyers JL; Blanke CD; Choy H; Stewart JR
    Ann Thorac Surg; 1998 Jan; 65(1):176-80; discussion 180-1. PubMed ID: 9456113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
    Heitmiller RF; Redmond M; Hamilton SR
    Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study.
    Szachnowicz S; Cecconello I; Ribeiro U; Iriya K; El Ibrahim R; Takeda FR; Corbett CE; Vaz Safatle-Ribeiro A
    World J Surg Oncol; 2009 Mar; 7():27. PubMed ID: 19272137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited resection for early adenocarcinoma in Barrett's esophagus.
    Stein HJ; Feith M; Mueller J; Werner M; Siewert JR
    Ann Surg; 2000 Dec; 232(6):733-42. PubMed ID: 11088068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.